奇托桑甲基醇-酸复合水凝和冷凝具有抗微生物和静血性质
Liang-Jyun Huang1, Shih-Ho Lin1, Tsai-Yu Chen1
1Institute of Polymer Science and Engineering, National Taiwan University, Taipei 106319, Taiwan.
International journal of biological macromolecules
|May 16, 2024
概括
这项研究开发了自愈的水凝和冷凝,这些水凝是从基托甲基醇和酸中制成的. 这些材料表现出增强的粘附性,机械强度和静血性质,显示出生物医学应用的前景.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 组织工程是组织工程.
背景情况:
- 含有catechol的水凝在生物医学用途中具有强大的粘附性和生物相容性.
- 奇托甲基醇水凝显示出潜力,但受和稳定性差的困扰.
- 开发强大的,自我愈合的基于catechol的水凝对于先进的生物材料至关重要.
研究的目的:
- 通过使用奇托甲基醇 (CC) 和酸 (TA) 合成和表征新型的自我愈合水凝和冷凝.
- 调查结构-属性关系,控制CC-TA复合材料的凝,机械行为和自我修复能力.
- 评估CC-TA复合材料在生物医学应用中的潜力,包括静血,药物输送和组织再生.
主要方法:
- 合成高替代性奇托甲基醇 (CC) 和其与酸 (TA) 的组合.
- 使用风湿测量,小角度X射线散射 (SAXS) 和机械测试进行CC-TA水凝和冷凝的表征.
- 制造CC-TA冷凝成静血抹布,并评估它们的特性.
主要成果:
- 高替代CC (∼28%) 与TA结合,形成了具有强化力学 (剪切模量∼110Pa) 的快速自我修复的水凝.
- 在现场SAXS和风力测量揭示了中介尺度集群 (∼20纳米),负责在剪切下动态破坏和自我修复.
- CC-TA冷凝表现出巨孔结构 (∼200微米),高胀率 (∼7000%) 和静血能力,以及ROS清除,抗菌活性和细胞兼容性.
结论:
- CC-TA复合水凝和冷凝显示出快速凝,增强的机械性能和有效的自我愈合.
- 独特的中尺度集群形态决定了水凝的动态和自我愈合行为.
- 由于其可调性特性和多功能性,CC-TA复合材料显示出各种生物医学应用的巨大潜力.
相关概念视频
Types of Toxins
3.6K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.6K
Toxic Reactions: Overview
4.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
379
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
379
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Bioactivation and Tissue Toxicity
151
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151
Toxicity Testing in Animals
200
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
200


